[
  {
    "text": "Antibiotics: behind the scenes, \nthey enable much of modern medicine.",
    "start": 6.841,
    "duration": 5.024
  },
  {
    "text": "We use them to cure infectious diseases,",
    "start": 11.865,
    "duration": 2.62
  },
  {
    "text": "but also to safely facilitate everything \nfrom surgery to chemotherapy",
    "start": 14.485,
    "duration": 5.122
  },
  {
    "text": "to organ transplants.",
    "start": 19.607,
    "duration": 2.0
  },
  {
    "text": "Without antibiotics,",
    "start": 21.607,
    "duration": 1.563
  },
  {
    "text": "even routine medical procedures \ncan lead to life-threatening infections.",
    "start": 23.17,
    "duration": 4.688
  },
  {
    "text": "And we’re at risk of losing them.",
    "start": 27.858,
    "duration": 2.93
  },
  {
    "text": "Antibiotics are chemicals \nthat prevent the growth of bacteria.",
    "start": 30.788,
    "duration": 4.162
  },
  {
    "text": "Unfortunately, some bacteria \nhave become resistant",
    "start": 34.95,
    "duration": 3.921
  },
  {
    "text": "to all currently available antibiotics.",
    "start": 38.871,
    "duration": 3.399
  },
  {
    "text": "At the same time, \nwe’ve stopped discovering new ones.",
    "start": 42.27,
    "duration": 4.01
  },
  {
    "text": "Still, there’s hope that we can get ahead \nof the problem.",
    "start": 46.28,
    "duration": 3.393
  },
  {
    "text": "But first, how did we \nget into this situation?",
    "start": 49.673,
    "duration": 3.487
  },
  {
    "text": "The first widely used antibiotic \nwas penicillin,",
    "start": 53.16,
    "duration": 3.374
  },
  {
    "text": "discovered in 1928 by Alexander Fleming.",
    "start": 56.534,
    "duration": 3.676
  },
  {
    "text": "In his 1945 Nobel Prize \nacceptance speech,",
    "start": 60.21,
    "duration": 3.784
  },
  {
    "text": "Fleming warned that bacterial resistance \nhad the potential to ruin",
    "start": 63.994,
    "duration": 4.713
  },
  {
    "text": "the miracle of antibiotics.",
    "start": 68.707,
    "duration": 2.28
  },
  {
    "text": "He was right: in the 1940s and 50s,",
    "start": 70.987,
    "duration": 3.007
  },
  {
    "text": "resistant bacteria \nalready began to appear.",
    "start": 73.994,
    "duration": 3.91
  },
  {
    "text": "From then until the 1980s,",
    "start": 77.904,
    "duration": 2.33
  },
  {
    "text": "pharmaceutical companies \ncountered the problem of resistance",
    "start": 80.234,
    "duration": 3.512
  },
  {
    "text": "by discovering many new antibiotics.",
    "start": 83.746,
    "duration": 2.998
  },
  {
    "text": "At first this was a highly successful— \nand highly profitable— enterprise.",
    "start": 86.744,
    "duration": 5.488
  },
  {
    "text": "Over time, a couple things changed.",
    "start": 92.232,
    "duration": 2.86
  },
  {
    "text": "Newly discovered antibiotics \nwere often only effective",
    "start": 95.092,
    "duration": 3.49
  },
  {
    "text": "for a narrow spectrum of infections,",
    "start": 98.582,
    "duration": 2.91
  },
  {
    "text": "whereas the first ones \nhad been broadly applicable.",
    "start": 101.492,
    "duration": 3.346
  },
  {
    "text": "This isn’t a problem in itself,",
    "start": 104.838,
    "duration": 1.974
  },
  {
    "text": "but it does mean that fewer doses \nof these drugs could be sold—",
    "start": 106.812,
    "duration": 4.26
  },
  {
    "text": "making them less profitable.",
    "start": 111.072,
    "duration": 2.414
  },
  {
    "text": "In the early days, \nantibiotics were heavily overprescribed,",
    "start": 113.486,
    "duration": 3.966
  },
  {
    "text": "including for viral infections \nthey had no effect on.",
    "start": 117.452,
    "duration": 3.81
  },
  {
    "text": "Scrutiny around prescriptions increased, \nwhich is good, but also lowered sales.",
    "start": 121.262,
    "duration": 5.489
  },
  {
    "text": "At the same time, \ncompanies began to develop more drugs",
    "start": 126.751,
    "duration": 3.63
  },
  {
    "text": "that are taken over a patient’s lifetime,",
    "start": 130.381,
    "duration": 2.585
  },
  {
    "text": "like blood pressure \nand cholesterol medications,",
    "start": 132.966,
    "duration": 2.66
  },
  {
    "text": "and later anti-depressants \nand anti-anxiety medications.",
    "start": 135.626,
    "duration": 4.52
  },
  {
    "text": "Because they are taken indefinitely, \nthese drugs more profitable.",
    "start": 140.146,
    "duration": 4.796
  },
  {
    "text": "By the mid-1980s, no new chemical classes \nof antibiotics were discovered.",
    "start": 144.942,
    "duration": 5.847
  },
  {
    "text": "But bacteria continued to acquire \nresistance and pass it along",
    "start": 150.789,
    "duration": 4.38
  },
  {
    "text": "by sharing genetic information \nbetween individual bacteria",
    "start": 155.169,
    "duration": 4.141
  },
  {
    "text": "and even across species.",
    "start": 159.31,
    "duration": 2.416
  },
  {
    "text": "Now bacteria that are resistant \nto many antibiotics are common,",
    "start": 161.726,
    "duration": 4.49
  },
  {
    "text": "and increasingly some strains \nare resistant to all our current drugs.",
    "start": 166.216,
    "duration": 5.738
  },
  {
    "text": "So, what can we do about this?",
    "start": 171.954,
    "duration": 2.38
  },
  {
    "text": "We need to control the use \nof existing antibiotics, create new ones,",
    "start": 174.334,
    "duration": 4.457
  },
  {
    "text": "combat resistance to new \nand existing drugs,",
    "start": 178.791,
    "duration": 3.352
  },
  {
    "text": "and find new ways to fight \nbacterial infections.",
    "start": 182.143,
    "duration": 3.938
  },
  {
    "text": "The largest consumer \nof antibiotics is agriculture,",
    "start": 186.081,
    "duration": 3.94
  },
  {
    "text": "which uses antibiotics not only \nto treat infections",
    "start": 190.021,
    "duration": 3.38
  },
  {
    "text": "but to promote the growth of food animals.",
    "start": 193.401,
    "duration": 3.01
  },
  {
    "text": "Using large volumes of antibiotics",
    "start": 196.411,
    "duration": 2.57
  },
  {
    "text": "increases the bacteria’s exposure \nto the antibiotics",
    "start": 198.981,
    "duration": 3.5
  },
  {
    "text": "and therefore their opportunity \nto develop resistance.",
    "start": 202.481,
    "duration": 4.37
  },
  {
    "text": "Many bacteria that are common in animals, \nlike salmonella, can also infect humans,",
    "start": 206.851,
    "duration": 5.485
  },
  {
    "text": "and drug-resistant versions can pass \nto us through the food chain",
    "start": 212.336,
    "duration": 4.577
  },
  {
    "text": "and spread through international trade \nand travel networks.",
    "start": 216.913,
    "duration": 4.543
  },
  {
    "text": "In terms of finding new antibiotics,",
    "start": 221.456,
    "duration": 2.73
  },
  {
    "text": "nature offers the most promising \nnew compounds.",
    "start": 224.186,
    "duration": 3.269
  },
  {
    "text": "Organisms like other microbes and fungi \nhave evolved over millions of years",
    "start": 227.455,
    "duration": 4.976
  },
  {
    "text": "to live in competitive environments—",
    "start": 232.431,
    "duration": 2.23
  },
  {
    "text": "meaning they often contain \nantibiotic compounds",
    "start": 234.661,
    "duration": 3.404
  },
  {
    "text": "to give them a survival advantage \nover certain bacteria.",
    "start": 238.065,
    "duration": 4.22
  },
  {
    "text": "We can also package antibiotics \nwith molecules that inhibit resistance.",
    "start": 242.285,
    "duration": 5.093
  },
  {
    "text": "One way bacteria develop resistance \nis through proteins of their own",
    "start": 247.378,
    "duration": 4.627
  },
  {
    "text": "that degrade the drug.",
    "start": 252.005,
    "duration": 1.74
  },
  {
    "text": "By packaging the antibiotic with molecules\nthat block the degraders,",
    "start": 253.745,
    "duration": 4.53
  },
  {
    "text": "the antibiotic can do its job.",
    "start": 258.275,
    "duration": 2.912
  },
  {
    "text": "Phages, viruses that attack bacteria \nbut don’t affect humans,",
    "start": 261.187,
    "duration": 4.428
  },
  {
    "text": "are one promising new avenue \nto combat bacterial infections.",
    "start": 265.615,
    "duration": 4.35
  },
  {
    "text": "Developing vaccines for common infections,\nmeanwhile,",
    "start": 269.965,
    "duration": 3.193
  },
  {
    "text": "can help prevent disease \nin the first place.",
    "start": 273.158,
    "duration": 3.437
  },
  {
    "text": "The biggest challenge to all \nthese approaches is funding,",
    "start": 276.595,
    "duration": 3.66
  },
  {
    "text": "which is woefully inadequate \nacross the globe.",
    "start": 280.255,
    "duration": 3.37
  },
  {
    "text": "Antibiotics are so unprofitable \nthat many large pharmaceutical companies",
    "start": 283.625,
    "duration": 4.865
  },
  {
    "text": "have stopped trying to develop them.",
    "start": 288.49,
    "duration": 2.38
  },
  {
    "text": "Meanwhile, smaller companies \nthat successfully bring new antibiotics",
    "start": 290.87,
    "duration": 3.775
  },
  {
    "text": "to market often still go bankrupt, \nlike the American start up Achaogen.",
    "start": 294.645,
    "duration": 5.702
  },
  {
    "text": "New therapeutic techniques \nlike phages and vaccines",
    "start": 300.347,
    "duration": 3.73
  },
  {
    "text": "face the same fundamental problem \nas traditional antibiotics:",
    "start": 304.077,
    "duration": 4.058
  },
  {
    "text": "if they’re working well, \nthey’re used just once,",
    "start": 308.135,
    "duration": 3.31
  },
  {
    "text": "which makes it difficult to make money.",
    "start": 311.445,
    "duration": 2.23
  },
  {
    "text": "And to successfully counteract resistance \nin the long term,",
    "start": 313.675,
    "duration": 3.4
  },
  {
    "text": "we’ll need to use \nnew antibiotics sparingly—",
    "start": 317.075,
    "duration": 3.52
  },
  {
    "text": "lowering the profits \nfor their creators even further.",
    "start": 320.595,
    "duration": 3.9
  },
  {
    "text": "One possible solution is to shift profits \naway from the volume of antibiotics sold.",
    "start": 324.495,
    "duration": 6.211
  },
  {
    "text": "For example, the United Kingdom \nis testing a model",
    "start": 330.706,
    "duration": 3.2
  },
  {
    "text": "where healthcare providers \npurchase antibiotic subscriptions.",
    "start": 333.906,
    "duration": 4.118
  },
  {
    "text": "While governments are looking for ways \nto incentivize antibiotic development,",
    "start": 338.024,
    "duration": 4.14
  },
  {
    "text": "these programs are still \nin the early stages.",
    "start": 342.164,
    "duration": 2.94
  },
  {
    "text": "Countries around the world \nwill need to do much more—",
    "start": 345.104,
    "duration": 3.31
  },
  {
    "text": "but with enough investment \nin antibiotic development",
    "start": 348.414,
    "duration": 3.55
  },
  {
    "text": "and controlled use of our current drugs,",
    "start": 351.964,
    "duration": 2.64
  },
  {
    "text": "we can still get ahead of resistance.",
    "start": 354.604,
    "duration": 2.65
  }
]